Imaging of hepatocellular carcinoma: diagnosis, staging and treatment monitoring
about
New approaches for precise response evaluation in hepatocellular carcinomaState-of-the-art imaging of liver fibrosis and cirrhosis: A comprehensive review of current applications and future perspectivesAssessment of clinical and radiological response to sorafenib in hepatocellular carcinoma patientsLiver masses: a clinical, radiologic, and pathologic perspective.Radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma conforming to the Milan criteria: systemic review and meta-analysisPrognostic factors for survival after transarterial chemoembolization combined with microwave ablation for hepatocellular carcinoma.Imaging for assessment of treatment response in hepatocellular carcinoma: Current update.Hepatocellular carcinoma: Advances in diagnosis, management, and long term outcome.Evaluation of 11C-acetate and 18F-FDG PET/CT in mouse multidrug resistance gene-2 deficient mouse model of hepatocellular carcinoma.Intravoxel Incoherent Motion Diffusion Weighted MR Imaging for Monitoring the Instantly Therapeutic Efficacy of Radiofrequency Ablation in Rabbit VX2 Tumors without Evident Links between Conventional Perfusion Weighted Images.Exophytic hepatocellular carcinoma, simulating a mesenchymal tumor, in a non-cirrhotic liver.Assessment of radiologic response to targeted therapies in patients with hepatocellular carcinoma.Scientific and industrial challenges of developing nanoparticle-based theranostics and multiple-modality contrast agents for clinical application.Implementation of LI-RADS into a radiological practice.Latest developments in precancerous lesions of hepatocellular carcinoma.Diagnostic performance of contrast-enhanced multidetector computed tomography and gadoxetic acid disodium-enhanced magnetic resonance imaging in detecting hepatocellular carcinoma: direct comparison and a meta-analysis.ADCtotal ratio and D ratio derived from intravoxel incoherent motion early after TACE are independent predictors for survival in hepatocellular carcinoma.Radiological Response to the Locoregional Treatment in Hepatocellular Carcinoma: RECIST, mRECIST, and Others.GPC-HCC model: a combination of glybican-3 with other routine parameters improves the diagnostic efficacy in hepatocellular carcinoma.From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world.Perfusion computed tomography for detection of hepatocellular carcinoma in patients with liver cirrhosis.Localized microbubble cavitation-based antivascular therapy for improving HCC treatment response to radiotherapy.Health economic assessment of Gd-EOB-DTPA MRI versus ECCM-MRI and multi-detector CT for diagnosis of hepatocellular carcinoma in China.Parametric response mapping of contrast-enhanced biphasic CT for evaluating tumour viability of hepatocellular carcinoma after TACE.Hepatocellular Carcinoma: Diagnosis, Treatment Algorithms, and Imaging Appearance after Transarterial Chemoembolization.Noninvasive imaging of hepatocellular carcinoma: From diagnosis to prognosis.A long-term survivor of undifferentiated carcinoma of the liver successfully treated with surgical treatments: A case report and literature review
P2860
Q26866367-1BB99B03-2E5F-4A5D-BF88-9180021ECFA0Q28085479-920EB576-2B85-4FC8-A568-AACBB6FC25C7Q28086977-29EBBAF9-F9D3-4831-BE2F-0C29CCED3670Q30403670-29CA2926-69F9-419E-A08F-7DC131D29815Q34547772-60BA7131-0FDD-4AE5-B62E-9B75ADC476D1Q34696783-A0171722-640D-4CB2-855E-CDE8A9C98C7EQ35568722-0764661A-175F-4368-929E-2B81555A7D19Q35626757-000C9106-A4AA-4C90-B152-7CA66B3DC9D8Q35633633-F2DF26D3-8DD9-48B0-A3AF-BABBDB19534CQ35644946-FE51CE31-7C57-4473-AAD9-04F2F4489FADQ37695892-D3C8F6C4-8E9E-4C4C-B7B3-4D6EF6FA67ABQ38268169-A02FE14D-9B06-4E7A-ABE6-AAA12C053E54Q38591130-7A44F949-113E-4852-8699-C75CF77C9636Q38716374-B53173DE-99AE-47C0-B50A-ED9BDBEB143BQ38791960-2E263AC7-3B3C-43CB-89C4-69C96BC8AEEDQ38869595-E4880EEB-5F5C-46DD-A35D-0877AB0D4CFBQ39169884-F1D4F2C0-3792-459A-945A-364894D22F88Q39380520-665BAAD8-B0C3-42D8-B345-F86BBC6275B6Q39630392-FE79D0D7-5EFD-45BE-8371-165E155E81C3Q40071003-9003107F-8545-475F-8666-72F027A946FDQ41027031-FB86B4B9-8C09-4D02-B829-D1F7B7A99628Q47609329-B61614CB-C4F7-4C73-9DD6-A41FA81677A2Q48259378-AD3BFF2E-D3C2-4B7F-9889-50AAB6DA53E2Q52985675-DF0815E3-4DF2-4D68-815B-5C590EEFBD6BQ55312644-FD519193-F906-4B61-8373-501D6274DED7Q55384238-717A32A4-93D2-4151-91D8-784B7BF94FC1Q58785310-454E87E7-FF36-43AA-923E-FE16DA7F0942
P2860
Imaging of hepatocellular carcinoma: diagnosis, staging and treatment monitoring
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Imaging of hepatocellular carcinoma: diagnosis, staging and treatment monitoring
@ast
Imaging of hepatocellular carcinoma: diagnosis, staging and treatment monitoring
@en
type
label
Imaging of hepatocellular carcinoma: diagnosis, staging and treatment monitoring
@ast
Imaging of hepatocellular carcinoma: diagnosis, staging and treatment monitoring
@en
prefLabel
Imaging of hepatocellular carcinoma: diagnosis, staging and treatment monitoring
@ast
Imaging of hepatocellular carcinoma: diagnosis, staging and treatment monitoring
@en
P2860
P1433
P1476
Imaging of hepatocellular carcinoma: diagnosis, staging and treatment monitoring
@en
P2093
Sudhakar Kundapur Venkatesh
Tiffany Hennedige
P2860
P304
P356
10.1102/1470-7330.2012.0044
P577
2013-02-08T00:00:00Z